Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
종목 코드 EMBC
회사 이름Embecta Corp
상장일Mar 21, 2022
CEOKurdikar (Devdatt)
직원 수1850
유형Ordinary Share
회계 연도 종료Mar 21
주소300 Kimball Drive
도시PARSIPPANY
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07054
전화18624010000
웹사이트https://www.embecta.com/
종목 코드 EMBC
상장일Mar 21, 2022
CEOKurdikar (Devdatt)